Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | BTN3A1 | O00481 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.34 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.34 |
| ▸ | FNTA | P49354 | 4/20 | 0.33 |
| ▸ | FNTB | P49356 | 4/20 | 0.33 |
| ▸ | PGGT1B | P53609 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL790445 | 0.98 | PPARD (0.38) | PPARDTSHRBTN3A1TDP1TP53 | |
| SCHEMBL6251753 | 0.92 | BTN3A1 (0.44) | PPARDTSHRBTN3A1TDP1TP53 | |
| SCHEMBL174096 | 0.89 | BTN3A1 (0.40) | TSHRBTN3A1LPAR3LPAR2FNTA | |
| Ethylene SCHEMBL28068723 | 0.86 | BTN3A1 (0.39) | TSHRBTN3A1LPAR3LPAR2FNTA | |
| Ammonia Solution, Strong SCHEMBL8023938 | 0.86 | BTN3A1 (0.39) | TSHRBTN3A1LPAR3LPAR2FNTA | |
| SCHEMBL11677557 | 0.86 | BTN3A1 (0.39) | TSHRBTN3A1LPAR3LPAR2FNTA | |
| SCHEMBL10625461 | 0.86 | BTN3A1 (0.39) | TSHRBTN3A1LPAR3LPAR2FNTA | |
| Dimethylamine SCHEMBL27846578 | 0.84 | BTN3A1 (0.39) | BTN3A1LPAR3LPAR2FNTAFNTB | |
| Sulfotep SCHEMBL2828854 | 0.84 | PPARD (0.35) | PPARDTSHRBTN3A1TDP1FNTA | |
| SCHEMBL4641076 | 0.83 | LPAR3 (0.36) | TSHRBTN3A1LPAR3LPAR2FNTA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 442 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12042487-B2 | Method for reducing side effects from administration of phosphodiesterase-4 inhibitors | ARCUTIS BIOTHERAPEUTICS, INC. (US) | 2024-07-23 | — | — | US | claimed |
| EP-4375419-A2 | METHOD OF MANUFACTURING A MULTI-RING CAN-HOLDER | E6PR S.A.P.I DE C.V. (MX) | 2024-05-29 | — | — | EP | claimed |
| US-20240024300-A1 | METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIESTERASE-4 INHIBITORS | ARCUTIS BIOTHERAPEUTICS, INC. (US) | 2024-01-25 | — | — | US | claimed |
| WO-2023083325-A1 | FLAME RETARDANT AND USE THEREOF, AND FIRE-RESISTANT EPOXY RESIN | 北京深云智合科技有限公司 | 2023-05-19 | — | — | WO | claimed |
| CN-116120634-A | Flame retardant, application thereof and fire-resistant epoxy resin | 北京深云智合科技有限公司 | 2023-05-16 | — | — | CN | claimed |
| CN-116120885-A | Adhesive, and preparation method and application thereof | 北京深云智合科技有限公司 | 2023-05-16 | — | — | CN | claimed |
| CN-115322309-B | Organosilicon acrylic emulsion and preparation method and application thereof | 广州海豚新材料有限公司 | 2023-05-09 | — | — | CN | claimed |
| CN-115322309-A | Organosilicon acrylic emulsion and preparation method and application thereof | 广州海豚新材料有限公司 | 2022-11-11 | — | — | CN | claimed |
| CN-112746347-A | Preparation method of halogen-free flame-retardant polyacrylonitrile fiber | 中国石油化工股份有限公司 | 2021-05-04 | — | — | CN | claimed |
| CN-109790277-B | Polyisocyanate composition, blocked polyisocyanate composition, coating composition, aqueous coating composition and coated substrate | 旭化成株式会社 | 2021-04-23 | — | — | CN | claimed |
| CN-105255159-A | Cured track bed sinking repairing high-viscosity vibration attenuation polyurethane repairing material | RAILWAY ENG RES INST CHINA ACADEMY RAILWAY SCIENCE | 2016-01-20 | — | — | CN | claimed |
| EP-1373447-B1 | A METHOD FOR REMOVING POLYMER FILMS IN THE MANUFACTURE OF AQUEOUS COMPOSITIONS CONTAINING ACRYLATES COPOLYMER | P & G CLAIROL INC (US) | 2011-01-19 | — | — | EP | claimed |
| EP-1383859-B1 | A METHOD FOR REMOVING POLYMER FILMS IN THE MANUFACTURE OF AQUEOUS COMPOSITIONS CONTAINING ANIONIC AMPHIPHILIC POLYMERS | P & G CLAIROL INC (US) | 2011-01-19 | — | — | EP | claimed |
| CN-100471393-C | Agrochemical composition | SYNGENTA LTD (GB) | 2009-03-25 | — | — | CN | claimed |
| CN-100471391-C | Agrochemical compositions | SYNGENTA LTD (GB) | 2009-03-25 | — | — | CN | claimed |
| US-6984268-B2 | Method for removing polymer films in the manufacture of aqueous compositions containing anionic amphiphilic polymers | THE PROCTER & GAMBLE COMPANY (US) | 2006-01-10 | — | — | US | claimed |
| US-6936113-B2 | Method for removing polymer films in the manufacture of aqueous compositions containing acrylates copolymer | THE PROCTER & GAMBLE COMPANY (US) | 2005-08-30 | — | — | US | claimed |
| US-20020183221-A1 | Method for removing polymer films in the manufacture of aqueous compositions containing acrylates copolymer | WELLA OPERATIONS US, LLC | 2002-12-05 | — | — | US | claimed |
| US-20020160923-A1 | Method for removing polymer films in the manufacture of aqueous compositions containing anionic amphiphilic polymers | NOXELL CORPORATION | 2002-10-31 | — | — | US | claimed |
| US-5330622-A | Applying glyoxal, dimeric alkylketene and diethanolamine salt of perfluoroalkyl ethyl phosphate to base with aid of impregnating press | AUSSEDAT-REY (FR) | 1994-07-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12042487-B2 | Method for reducing side effects from administration of phosphodiesterase-4 inhibitors | PDE12, PDE4A, SMPD4 | PPARD 1432/4885TSHR 3003/4885BTN3A1 4692/4885 |
| US-20240024300-A1 | METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIESTERASE-4 INHIBITORS | PDE12, PDE4A, SMPD4 | PPARD 1432/4885TSHR 3003/4885BTN3A1 4692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.